Advanced search
Publication Cover
Modern Rheumatology Volume 22, 2012 - Issue 4
Journal homepage
9
Views
0
CrossRef citations to date
0
Altmetric
Letter

Reply to: Comment on “Comparison of MMP-3 levels in rheumatoid arthritis after treatment with tocilizumab or infliximab for 12 weeks” by Yokoe et al.

Isamu YokoeDivision of Rheumatology, Itabashi Chuo Medical Center, 2-12-7 Azusawa, Itabashi-ku, Tokyo 1740051, Japan
,
Shinya NishioDivision of Rheumatology, Itabashi Chuo Medical Center, 2-12-7 Azusawa, Itabashi-ku, Tokyo 1740051, Japan
,
Hiroshi SatoDivision of Rheumatology, Itabashi Chuo Medical Center, 2-12-7 Azusawa, Itabashi-ku, Tokyo 1740051, Japan
&
Hitomi KobayashiDivision of Rheumatology, Itabashi Chuo Medical Center, 2-12-7 Azusawa, Itabashi-ku, Tokyo 1740051, JapanCorrespondence[email protected]
Pages 640-642 | Received 30 Nov 2011, Accepted 11 May 2012, Published online: 02 Jan 2014

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.